Can HIV-1-specific ADCC assist the clearance of reactivated latently infected cells?

Can HIV-1-specific ADCC assist the clearance of reactivated latently infected cells?

Bibliographic Details
Main Authors:	Wen Shi eLee, Matthew Sidney Parsons, Stephen John Kent, Marit eLichtfuss
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-05-01
Series:	Frontiers in Immunology
Subjects:	HIV antibody latency NK cell HIV cure Antibody-dependent cellular cytotoxicity (ADCC)
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00265/full

Similar Items

Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir
by: Poonam Suryawanshi, et al.
Published: (2021-04-01)

Improved HIV-positive infant survival is correlated with high levels of HIV-specific ADCC activity in multiple cohorts
by: Zak A. Yaffe, et al.
Published: (2021-04-01)

A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma
by: Emilie Decaup, et al.
Published: (2019-08-01)

ADCC against MICA/B is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor
by: Kawaljit Kaur, et al.
Published: (2021-01-01)

NK cell-based autologous immune enhancement therapy (AIET) for cancer (Invited Review)
by: Terunuma H, et al.
Published: (2013-04-01)

Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era
by: Pablo Mandó, et al.
Published: (2021-12-01)

Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1
by: George K. Lewis, et al.
Published: (2019-05-01)

Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
by: Matthew S. Parsons, et al.
Published: (2018-08-01)

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
by: Kate J. Dixon, et al.
Published: (2021-01-01)

Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies
by: Jorge Carrillo, et al.
Published: (2018-10-01)

Potential Utility of Natural Killer Cells for Eliminating Cells Harboring Reactivated Latent HIV-1 Following the Removal of CD8<sup>+</sup> T Cell-Mediated Pro-Latency Effect(s)
by: Georges Khoury, et al.
Published: (2021-07-01)

Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma
by: Margaux Lejeune, et al.
Published: (2021-06-01)

Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
by: Kimone Leigh Fisher, et al.
Published: (2020-07-01)

Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies
by: Laura E Doepker, et al.
Published: (2021-01-01)

In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells
by: Amanda G. Tomalka, et al.
Published: (2018-11-01)

Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
by: Jennifer J.-J. Tang, et al.
Published: (2020-10-01)

Efficient mRNA-based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7 Augments Rituximab-induced ADCC against Lymphoma and Targets NK cell Migration Towards the Lymph Node Associated Chemokine CCL19
by: Mattias eCarlsten, et al.
Published: (2016-03-01)

ADCC-Mediated CD56dim NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection
by: Wen-Han Yu, et al.
Published: (2018-02-01)

Deficient IL-2 Produced by Activated CD56+ T Cells Contributes to Impaired NK Cell-Mediated ADCC Function in Chronic HIV-1 Infection
by: Zhe Xie, et al.
Published: (2019-07-01)

“Universal Flu Vaccine”: Can NK Cell-mediated ADCC Tip the Scales?
by: Maya Hassane, et al.
Published: (2016-06-01)

TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure
by: Caroline Thue Hvilsom, et al.
Published: (2021-09-01)

Exploiting NK Cell Surveillance Pathways for Cancer Therapy
by: Alexander David Barrow, et al.
Published: (2019-01-01)

Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity
by: Zheng Yang, et al.
Published: (2018-11-01)

Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins
by: Jonathan Richard, et al.
Published: (2016-10-01)

Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells
by: Kristin M. Snyder, et al.
Published: (2018-12-01)

Natural killer cells for immunotherapy – Advantages of cell lines over blood NK cells
by: Hans eKlingemann, et al.
Published: (2016-03-01)

Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects
by: Franck P. Dupuy, et al.
Published: (2019-12-01)

Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity
by: Charles D. Murin
Published: (2020-07-01)

Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers
by: Sanket Kant, et al.
Published: (2020-09-01)

Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function
by: Rongyuan Gao, et al.
Published: (2020-03-01)

Monoclonal Antibodies in Cancer Therapy
by: David Zahavi, et al.
Published: (2020-07-01)

Influenza and Antibody-Dependent Cellular Cytotoxicity
by: Tarra A. Von Holle, et al.
Published: (2019-06-01)

Editorial: Exploring Novel Approaches to Eliminate HIV Reservoirs to Achieve a Cure for HIV
by: Renée M. van der Sluis, et al.
Published: (2021-02-01)

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
by: Dieter Mielke, et al.
Published: (2019-12-01)

Systems serology: profiling vaccine induced humoral immunity against HIV
by: Amy W. Chung, et al.
Published: (2017-12-01)

A diverse collection of B cells responded to HIV infection in infant BG505
by: Cassandra Simonich, et al.
Published: (2021-06-01)

Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
by: Rena Liu, et al.
Published: (2020-11-01)

Antitumour Activity of a Hinge- and Fc-engineered Chimeric Heavy-chain Antibody
by: D'Eall, Calvin
Published: (2015)

HIV Latency Reversing Agents have diverse effects on Natural Killer Cell Function
by: Carolina Garrido, et al.
Published: (2016-09-01)

Potential for Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity for Control of Human Cytomegalovirus
by: Rebecca J. Aicheler, et al.
Published: (2013-12-01)